|
1
|
Wright K: Acute and chronic wounds:
current managment concepts. Clin Nurse Spec. 21:172–173. 2007.
View Article : Google Scholar
|
|
2
|
Vowden K, Vowden P and Posnett J: The
resource costs of wound care in Bradford and Airedale primary care
trust in the UK. J Wound Care. 18:93–94. 96–98, 100 passim. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Posnett J and Franks PJ: The burden of
chronic wounds in the UK. Nurs Times. 104:44–45. 2008.PubMed/NCBI
|
|
4
|
Drew P, Posnett J and Rusling L; Wound
Care Audit T; Wound Care Audit Team: The cost of wound care for a
local population in England. Int Wound J. 4:149–155. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schilling JA: Wound healing. Surg Clin
North Am. 56:859–874. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grabstein KH, Eisenman J, Shanebeck K,
Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn
MA, Ahdieh M, et al: Cloning of a T cell growth factor that
interacts with the beta chain of the interleukin-2 receptor.
Science. 264:965–968. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Giri JG, Anderson DM, Kumaki S, Park LS,
Grabstein KH and Cosman D: IL-15, a novel T cell growth factor that
shares activities and receptor components with IL-2. J Leukoc Biol.
57:763–766. 1995.PubMed/NCBI
|
|
8
|
Carson WE, Giri JG, Lindemann MJ, Linett
ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K and
Caligiuri MA: Interleukin (IL) 15 is a novel cytokine that
activates human natural killer cells via components of the IL-2
receptor. J Exp Med. 180:1395–1403. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Waldmann TA and Tagaya Y: The multifaceted
regulation of interleukin-15 expression and the role of this
cytokine in NK cell differentiation and host response to
intracellular pathogens. Annu Rev Immunol. 17:19–49. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tagaya Y, Burton JD, Miyamoto Y and
Waldmann TA: Identification of a novel receptor/signal transduction
pathway for IL-15/T in mast cells. EMBO J. 15:4928–4939.
1996.PubMed/NCBI
|
|
11
|
Rückert R, Asadullah K, Seifert M,
Budagian VM, Arnold R, Trombotto C, Paus R and Bulfone-Paus S:
Inhibition of keratinocyte apoptosis by IL-15: a new parameter in
the pathogenesis of psoriasis? J Immunol. 165:2240–2250. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yano S, Komine M, Fujimoto M, Okochi H and
Tamaki K: Interleukin 15 induces the signals of epidermal
proliferation through ERK and PI 3-kinase in a human epidermal
keratinocyte cell line, HaCaT. Biochem Biophys Res Commun.
301:841–847. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lindner G, Rückert R, Bulfone-Paus S and
Paus R: Inhibition of chemotherapy-induced keratinocyte apoptosis
in vivo by an interleukin-15-IgG fusion protein. J Invest Dermatol.
110:457–458. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Suzuki A, McCall S, Choi SS, Sicklick JK,
Huang J, Qi Y, Zdanowicz M, Camp T, Li YX and Diehl AM:
Interleukin-15 increases hepatic regenerative activity. J Hepatol.
45:410–418. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kagimoto Y, Yamada H, Ishikawa T, Maeda N,
Goshima F, Nishiyama Y, Furue M and Yoshikai Y: A regulatory role
of interleukin 15 in wound healing and mucosal infection in mice. J
Leukoc Biol. 83:165–172. 2008. View Article : Google Scholar
|
|
16
|
McInnes IB and Gracie JA: Interleukin-15:
A new cytokine target for the treatment of inflammatory diseases.
Curr Opin Pharmacol. 4:392–397. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bosanquet DC, Harding KG, Ruge F, Sanders
AJ and Jiang WG: Expression of IL-24 and IL-24 receptors in human
wound tissues and the biological implications of IL-24 on
keratinocytes. Wound Repair Regen. 20:896–903. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang WG, Martin TA, Lewis-Russell JM,
Douglas-Jones A, Ye L and Mansel RE: Eplin-alpha expression in
human breast cancer, the impact on cellular migration and clinical
outcome. Mol Cancer. 7:712008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Keese CR, Wegener J, Walker SR and Giaever
I: Electrical wound-healing assay for cells in vitro. Proc Natl
Acad Sci USA. 101:1554–1559. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tinhofer I, Marschitz I, Henn T, Egle A
and Greil R: Expression of functional interleukin-15 receptor and
autocrine production of interleukin-15 as mechanisms of tumor
propagation in multiple myeloma. Blood. 95:610–618. 2000.PubMed/NCBI
|
|
21
|
Leroy S, Dubois S, Tenaud I, Chebassier N,
Godard A, Jacques Y and Dréno B: Interleukin-15 expression in
cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
Br J Dermatol. 144:1016–1023. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kukita T, Arima N, Matsushita K, Arimura
K, Ohtsubo H, Sakaki Y, Fujiwara H, Ozaki A, Matsumoto T and Tei C:
Autocrine and/or paracrine growth of adult T-cell leukaemia tumour
cells by interleukin 15. Br J Haematol. 119:467–474. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bamford RN, Battiata AP and Waldmann TA:
IL-15: the role of translational regulation in their expression. J
Leukoc Biol. 59:476–480. 1996.PubMed/NCBI
|
|
24
|
Moore K, Ruge F and Harding KG: T
lymphocytes and the lack of activated macrophages in wound margin
biopsies from chronic leg ulcers. Br J Dermatol. 137:188–194. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kurys G, Tagaya Y, Bamford R, Hanover JA
and Waldmann TA: The long signal peptide isoform and its
alternative processing direct the intracellular trafficking of
interleukin-15. J Biol Chem. 275:30653–30659. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Blauvelt A, Asada H, Klaus-Kovtun V,
Altman DJ, Lucey DR and Katz SI: Interleukin-15 mRNA is expressed
by human keratinocytes Langerhans cells, and blood-derived
dendritic cells and is downregulated by ultraviolet B radiation. J
Invest Dermatol. 106:1047–1052. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kuniyasu H, Ohmori H, Sasaki T, Sasahira
T, Yoshida K, Kitadai Y and Fidler IJ: Production of interleukin 15
by human colon cancer cells is associated with induction of mucosal
hyperplasia, angiogenesis, and metastasis. Clin Cancer Res.
9:4802–4810. 2003.PubMed/NCBI
|
|
28
|
Shinozaki M, Hirahashi J, Lebedeva T, Liew
FY, Salant DJ, Maron R and Kelley VR: IL-15, a survival factor for
kidney epithelial cells, counteracts apoptosis and inflammation
during nephritis. J Clin Invest. 109:951–960. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hjorth-Hansen H, Waage A and Börset M:
Interleukin-15 blocks apoptosis and induces proliferation of the
human myeloma cell line OH-2 and freshly isolated myeloma cells. Br
J Haematol. 106:28–34. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park SL, Kim WJ and Moon SK: p21WAF1
mediates the IL-15-induced migration and invasion of human bladder
cancer 5637 cells via the ERK1/2/NF-κB/MMP-9 pathway. Int
Immunopharmacol. 22:59–65. 2014. View Article : Google Scholar : PubMed/NCBI
|
